Search

everythinglearnresearchcommunity

for

Search:↓

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

A 38-year-old man was diagnosed late with Kearns-Sayre syndrome after being wrongly treated for epilepsy.

VPS13C variants are linked to more severe REM sleep disorder and faster progression to Parkinson's disease.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

Low-level laser therapy can help with inflammation but isn't widely accepted yet.

Signaling pathways are key targets for developing effective drugs.

Customizing non-invasive treatments for head and neck neuralgia improves patient outcomes.

Alopecia can lead to mental health issues, so treatment should address both skin and emotional health.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

A patient with myotonic dystrophy had several autoimmune disorders and thyroid cancer, suggesting a possible link between these conditions.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Some migraine sufferers had no more headaches after getting a hair transplant.

The model and estimator can predict drug exposure in kidney transplant patients well.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Managing malignant ureteral obstruction is challenging and requires personalized treatment to protect kidney function and patient health.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Surgery, especially prostatectomy, effectively reduces detrusor overactivity in bladder outlet obstruction patients.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.